Molecule intelOpportunity: Lower0

Promethazine Hci

8 brands · 8 companies · product forms

2 DRAP alerts

Opportunity snapshot

Launch attractiveness
14
Market saturation
20
Price room
0
Regulatory risk
60
8
brands
8
companies
0
price points
0x
price spread
65
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 13%

Regulatory alerts

latest 2025-04-07
Safety Alert risk of severe chemical irritation and damage to tissues with Promethazine hy
WHO Global Alert on Contaminated Pediatrics Cough Syrups Identified In Gambia-West Africa

Why this score

Launch attractiveness

40% supply-gap(0) + 25% price-variation(0) + 20% low-competition(80) + 15% supply-disruption(0), damped by confidence(65). Higher = more attractive, less crowded opportunity.

Market saturation

8 canonical companies and 8 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

Only 0 trusted price points; variation not scored (low data).

Regulatory risk

2 DRAP alert(s), latest 2025-04-07.

Confidence

Reduced by: sparse price data, no ATC code.

Packaged brief for this lower opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.